Encube Ethicals
Bengaluru, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $20M
Overview
A private Indian biotech delivering nano‑emulsion based dermatology drugs with enhanced skin penetration.
DermatologyDrug Delivery
Technology Platform
Proprietary nano‑emulsion system (Encube‑Nano) that creates sub‑100 nm droplets to enhance skin penetration and controlled release of diverse APIs.
Opportunities
Expanding the nano‑emulsion platform to systemic transdermal delivery and securing strategic partnerships for global market entry.
Risk Factors
Clinical efficacy may not meet expectations; regulatory hurdles and scaling manufacturing could delay timelines.
Competitive Landscape
Competes with companies like Almirall and Johnson & Johnson in dermatology; differentiation lies in its nano‑emulsion technology that enhances skin penetration.